Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New experimental data on Asahi Chemical's ART-123

April 3, 1997

Corvas begins phase Ia trial of rNAPc2

April 3, 1997

Menarini prepares thrombin inhibitors

April 3, 1997

New thrombin inhibitors from Novartis

April 3, 1997

VIMRx licenses factor IXa inhibitor from Columbia University

April 2, 1997

First generic warfarin product cleared by the FDA

April 1, 1997

Genzyme Transgenics receives further funding for development of transgenic ATIII

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...